Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Rhea-AI Summary

Talphera (Nasdaq: TLPH) will release third quarter 2025 financial results after market close on Wednesday, November 12, 2025.

The company will host a live webcast and conference call on Nov 12, 2025 at 4:30 p.m. ET / 1:30 p.m. PT to discuss results and provide a corporate update. The webcast includes a slide presentation and a replay that will be available on the Talphera investor website for 90 days after the event.

Investors can join the conference call via 1-800-836-8184 (North America) or 1-646-357-8785 (international); conference ID 08207. Webcast links are posted in Investors > News & Events > Upcoming Events at www.talphera.com.

SAN MATEO, Calif., Nov. 5, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release third quarter 2025 financial results after market close on Wednesday, November 12, 2025, then host a live webcast and conference call at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss the results and provide an update on the Company's business.

Webcast Information

The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.

Conference Call Information

Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of Canada. The conference ID is 08207.

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-third-quarter-financial-results-and-corporate-update-call-and-webcast-on-wednesday-november-12-2025-302604832.html

SOURCE Talphera, Inc.

FAQ

When will Talphera (TLPH) release Q3 2025 financial results?

Talphera will release Q3 2025 results after market close on Wednesday, November 12, 2025.

What time is the Talphera (TLPH) earnings webcast and conference call on Nov 12, 2025?

The live webcast and conference call begin at 4:30 p.m. ET / 1:30 p.m. PT on Nov 12, 2025.

How can investors access the Talphera (TLPH) webcast for the Q3 2025 results?

Access the webcast via the Investors section at www.talphera.com under News & Events > Upcoming Events or via the direct webcast link.

What are the dial‑in numbers and conference ID for Talphera's Nov 12, 2025 call?

North America callers: 1-800-836-8184; International: 1-646-357-8785 (toll applies); Conference ID: 08207.

Will Talphera (TLPH) provide slides or a replay of the Q3 2025 webcast?

Yes. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days after the event.

Where can I find Talphera (TLPH) investor materials after the Nov 12, 2025 presentation?

Investor materials and the webcast replay will be posted in Investors > News & Events > Upcoming Events at www.talphera.com.